CA2478901A1 - Methods of virus production - Google Patents

Methods of virus production Download PDF

Info

Publication number
CA2478901A1
CA2478901A1 CA002478901A CA2478901A CA2478901A1 CA 2478901 A1 CA2478901 A1 CA 2478901A1 CA 002478901 A CA002478901 A CA 002478901A CA 2478901 A CA2478901 A CA 2478901A CA 2478901 A1 CA2478901 A1 CA 2478901A1
Authority
CA
Canada
Prior art keywords
virus
temperature
culture
cell
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002478901A
Other languages
English (en)
French (fr)
Inventor
Liangzhi Xie
Charles F. Goochee
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp and Dohme LLC
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2478901A1 publication Critical patent/CA2478901A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10341—Use of virus, viral particle or viral elements as a vector
    • C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10351—Methods of production or purification of viral material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
CA002478901A 2002-03-29 2003-03-27 Methods of virus production Abandoned CA2478901A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US36865402P 2002-03-29 2002-03-29
US60/368,654 2002-03-29
PCT/US2003/009269 WO2003085138A1 (en) 2002-03-29 2003-03-27 Methods of virus production

Publications (1)

Publication Number Publication Date
CA2478901A1 true CA2478901A1 (en) 2003-10-16

Family

ID=28791896

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002478901A Abandoned CA2478901A1 (en) 2002-03-29 2003-03-27 Methods of virus production

Country Status (9)

Country Link
US (1) US7344873B2 (enExample)
EP (1) EP1492891B1 (enExample)
JP (1) JP4413012B2 (enExample)
AT (1) ATE386824T1 (enExample)
AU (1) AU2003226012B2 (enExample)
CA (1) CA2478901A1 (enExample)
DE (1) DE60319210T2 (enExample)
ES (1) ES2299715T3 (enExample)
WO (1) WO2003085138A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2008248905B2 (en) 2007-05-04 2014-05-29 Nanotherapeutics, Inc. Two-step temperature profile for the propagation of viruses
JP2013523175A (ja) 2010-04-14 2013-06-17 イーエムディー・ミリポア・コーポレーション 高力価、高純度のウイルスストックの作製方法及びその使用方法
US20110262965A1 (en) 2010-04-23 2011-10-27 Life Technologies Corporation Cell culture medium comprising small peptides
WO2012122625A1 (en) 2011-03-14 2012-09-20 National Research Council Of Canada Method of viral production in cells

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3962424A (en) * 1974-01-31 1976-06-08 Recherche Et Industrie Therapeutiques (R.I.T.) Live brovine adenovirus vaccines, preparation thereof and method of vaccination using them
US5618714A (en) * 1993-12-15 1997-04-08 Eli Lilly And Company Methods for producing protein C
US5837520A (en) * 1995-03-07 1998-11-17 Canji, Inc. Method of purification of viral vectors
KR100470180B1 (ko) * 1995-06-15 2005-02-04 크루셀 홀란드 비.브이. 유전자 요법에 사용할 수 있는 인간의 재조합아데노바이러스 패키징 시스템
JP2003530307A (ja) 1999-07-06 2003-10-14 メルク・アンド・カンパニー・インコーポレーテッド ｇａｇ遺伝子保有アデノウイルスＨＩＶワクチン
CA2422882A1 (en) 2000-09-15 2002-03-21 Merck & Co., Inc. Enhanced first generation adenovirus vaccines expressing codon optimized hiv1-gag, pol, nef and modifications

Also Published As

Publication number Publication date
EP1492891A1 (en) 2005-01-05
AU2003226012B2 (en) 2007-05-24
JP2005521423A (ja) 2005-07-21
WO2003085138A1 (en) 2003-10-16
DE60319210T2 (de) 2009-02-12
US7344873B2 (en) 2008-03-18
ATE386824T1 (de) 2008-03-15
DE60319210D1 (de) 2008-04-03
AU2003226012A1 (en) 2003-10-20
US20050176146A1 (en) 2005-08-11
ES2299715T3 (es) 2008-06-01
JP4413012B2 (ja) 2010-02-10
EP1492891B1 (en) 2008-02-20
EP1492891A4 (en) 2005-08-24

Similar Documents

Publication Publication Date Title
CN102203242B (zh) 产生腺病毒载体的方法
RU2359999C2 (ru) Иммортализованные линии клеток птиц для получения вирусов
KR102044051B1 (ko) 터미널 말단이 변경된 재조합 아데노바이러스의 배치
JP2013165736A (ja) ウイルス産生プロセス
Dormond et al. From the first to the third generation adenoviral vector: what parameters are governing the production yield?
US20180080010A1 (en) Method for the production of ad26 adenoviral vectors
MX2012007936A (es) Metodo para la produccion de vectores adenovirales del serotipo 26 del adenovirus.
Shen et al. Process optimization and scale-up for production of rabies vaccine live adenovirus vector (AdRG1. 3)
JP2015535687A (ja) 新規ｍｖａウイルス及びその使用
WO2021139147A1 (zh) 一种腺病毒二价疫苗
EP1492891B1 (en) Methods of virus production
US20090253184A1 (en) Compositions and methods related to an adenoviral trans-complementing cell line
Trabelsi et al. Development of an efficient veterinary rabies vaccine production process in the avian suspension cell line AGE1. CR. pIX
Fernandes et al. Upstream bioprocess for adenovirus vectors
CN116829702A (zh) 生产腺病毒的方法
US20240033345A1 (en) Method for producing virus
Subramanian et al. Scaleable production of adenoviral vectors by transfection of adherent PER. C6 cells
CN1231598C (zh) 一种重组禽腺病毒的制备方法
EP2970916B1 (en) Adapted lepidopteran insect cells for the production of recombinant proteins
Kirilin et al. Adenovirus Serotype 26 Cultivation on a Production Scale: Optimization of Conditions
CN118086390A (zh) 一种一步构建猪流行性腹泻病毒感染性质粒的方法与应用
CN120738288A (zh) 重组腺病毒载体和基于该载体的复制型腺病毒重组体及其构建方法
JPH0622758A (ja) 新規な新症候出血熱ワクチンおよびその製造方法
Silvaa et al. Scalable culture systems using different cell lines for the production of Peste des Petits ruminants vaccine
Wissing et al. CAP® AD–A VERSATILE PLATFORM FOR RCA-FREE, INDUSTRIAL SCALE ADENOVIRAL VECTOR PRODUCTION

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued